Patent ID: 11939335
Assignee: 858 THERAPEUTICS, INC.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C | IPC A  C

Claim 14:
15. The compound of claim 13, or a pharmaceutically acceptable salt, deuteroisotope, or stereoisomer thereof, wherein R1 is alkyl(pyrazolyl);
wherein the alkyl portion of alkyl(pyrazolyl) is optionally substituted with one or more substituents independently selected from the group consisting of D, halo, CN, NO2, C(O)Ra, C(O)N(Ra)2, C(O)ORa, N(Ra)2, NRaC(O)Ra, NRaC(O)ORa, NRaS(O)tRa, ORa, OC(O)Ra, OC(O)N(Ra)2, OC(O)ORa, ORcC(O)N(Ra)2, ═O, S(O)tRa, S(O)tN(Ra)2, S(O)tORa, ═S, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl; and
wherein the pyrazolyl is optionally substituted with one or more independently selected C1-C5 alkyl substituents.